NetworkNewsBreaks – CytoDyn Inc. (CYDY) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced the featured interview of its President and CEO Nader Z. Pourhassan, Ph.D. with Stock Day’s Everett Jolly. Jolly initiated the discussion by asking about CytoDyn’s PRO 140. The company’s flagship product is a humanized IgG4 monoclonal antibody that is designed to bind to cellular receptor CCR5, which plays various roles with implications in HIV, tumor metastasis and immune signaling. Pending FDA approval, which the company hopes to secure in Q4 2019, Pourhassan indicates that PRO 140 may be available to the public in 2020.  “Most biotech companies, when they finish the biologic application, they have an 85% chance to get approved. 9 out of 10 who don’t get approved is because of the safety of the product. Our product has received fast track designation due to having great safety among all of the approved drugs,” Nader Z. Pourhassan, Ph.D., president and CEO of CytoDyn, stated in the news release.

To hear the Stock Day Podcast featuring the interview, visit http://nnw.fm/kYJU8

To view the full press release, visit http://nnw.fm/4Q7xo

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Launches Comprehensive POS Solution, Aptito NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight Wins 2019 CES Innovation Award NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) Brings to Market its Cranberry & Shortbread Gummies: 2018 Holiday Limited Edition

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Biz Daily Online

Global shares stumble following retreat on Wall Street

Mar 25, 2019

BANGKOK — Shares tumbled in Europe and Asia on Monday after Wall Street ended last week with a broad retreat. Thailand's benchmark dipped following a general election that appeared likely to keep the incumbent, junta-backed prime minister in power. Wall Street was roiled Friday by fresh signs that global economic growth is slowing. The jitters spurred a sell-off in stocks and sent bond yields sharply lower, flashing warning lights for a possible recession. Among the triggers was news that factory production in the euro currency alliance fell at its steepest rate in about six years, according to surveys of manufacturers'...

European shares shaken by Brexit jitters after gains in Asia

Mar 25, 2019

BANGKOK — Shares were mostly lower in Europe on Thursday and headed for a lower open on Wall Street amid Brexit uncertainties and after the Federal Reserve promised not to raise interest rates this year. Britain's FTSE 100 added 0.3 percent to 7,311, while the DAX in Germany lost 0.9 percent to 11,496. The CAC 40 in France slipped almost 0.5 percent to 5,357. Despite the Fed's promise not to raise interest rates and reports from China that U.S. officials would visit Beijing next week for another round of trade talks, Wall Street looked set to open lower. The future...

Asian shares gain as Fed says it will hold off on rate hikes

Mar 25, 2019

BANGKOK — Shares in Asia were mostly higher on Thursday after the Federal Reserve said it has ruled out interest rate increases for this year. The Shanghai Composite index advanced 0.6 percent to 3,109.48 while Hong Kong's Hang Seng gained 0.2 percent to 29,365.55. South Korea's Kospi climbed 0.3 percent to 2,182.77, while Australia's S&P ASX lost 0.5 percent to 6,137.20. Shares were higher in Taiwan and Southeast Asia. Japan's markets were closed for a national holiday. U.S. equities fell Wednesday, led by banks, after the central bank said it expects no interest rate increases this year and issued a...

World markets mostly lower as investors await Fed report

Mar 25, 2019

BANGKOK — Shares were mostly falling in Europe after a lackluster day of trading in Asia and U.S. markets appeared set for a slightly higher open ahead of the Federal Reserve's policy statement. Germany's DAX sank 1.2 percent to 11,644, dragged down by a profit warning by BMW and a court ruling against Bayer's Roundup weed killer. The CAC 40 in France gave up 0.1 percent to 5,419. Britain's FTSE 100 was flat at 7,325. Wall Street was on track for small gains when the market opens, with the future contract for the Dow Jones Industrial Average gaining 0.1 percent...

Asian markets trend lower, tracking Wall St losses

Mar 25, 2019

BANGKOK — Markets in Asia are mostly lower after a lackluster day of trading on Wall Street. Mixed signals on the progress of China-U.S. trade talks also revived caution in Chinese markets. The Shanghai Composite lost 1 percent to 3,059.17 in early trading Wednesday and Hong Kong's Hang Seng fell 0.5 percent to 29,318.53. Japan's Nikkei 225 index edged 0.1 percent higher to 21,577.82, while the S&P ASX 200 gave up 0.1 percent to 6,177.50. South Korea's Kospi sank 1.1 percent to 2,154.23. Shares were higher in Taiwan, Thailand and Indonesia but fell in Singapore. Investors are looking ahead to...

About Us

Biz Daily Online gives a complete understanding of the world of business to you. Get today’s business news and learn about the trends that are affecting every business here.

Contact us: sales[at]bizdailyonline.com

Subscribe Now!